Introduction {#s1}
============

Colonoscopy is vital for the diagnosis of colorectal diseases, being the current gold standard method for investigating the colonic, rectal, and terminal ileal mucosa \[[@R01]\]. This includes the entire mucosa from the anal margin to the ileocecal valve, and is particularly important in the context of screening/surveillance for colorectal cancer (CRC). This is relevant as colorectal cancer is a major cause of mortality worldwide, with an incidence of approximately 900,000 cases per year \[[@R02], [@R03]\]. Mortality and morbidity from colorectal cancer can be decreased if screening is performed on all individuals above the age of 50. Colonoscopy is not just a screening tool, but also plays a role in the diagnosis of proximally located colonic cancers which will not be detected with simple sigmoidoscopy \[[@R04]\].

Apart from the use of enemas and laxatives for bowel cleansing, devices specifically manufactured for cleansing have also been developed. One such device, ColonoScoPrep™ (Aquanet), was designed to use triple filtered water, carbon microsediments and ultraviolet light, while working within a fixed pressure and gravity system, thereby increasing intestinal washing efficiency \[[@R05]\]. It has been demonstrated that bowel cleansing devices (BCDs) such as Jetprep (Jetprep LLC, Herzliya, Israel), Medjet, and ColonoScoPrep™ improve intestinal cleansing, are safe, effective, and well tolerated by patients \[[@R05]-[@R07]\].

Colonoscopy procedures are commonly performed with high success rates. However, poor or inadequate bowel preparation is one of the most common reasons for a repeated or failed colonoscopy \[[@R08]\]. Inadequate bowel cleansing also has a negative impact on cecal intubation success rates, decreasing polyp detection and retrieval rates, increasing the time of the overall procedure, and ultimately affecting not only its effectiveness but also its safety \[[@R07], [@R08]\]. Factors predicting inadequate preparation include stroke, dementia, opioid use, calcium-channel blockers and anti-depressants \[[@R9]\]. In contrast, an adequately prepared colon enables a full view of the mucosa, hence reducing the rates of repeated examinations and also decreasing the rates of endoscopists missing lesions.

The success of a colonoscopy procedure is dependent on the effectiveness of its preparation. Preparation methods shown to be effective include the use of either BCDs or oral laxatives. The use of cleansing methods such as enemas and laxatives is important in increasing the sensitivity of the colonoscopy procedures. Most enemas have their causal mechanisms related to rectal distension and mucosa irritation \[[@R10], [@R11]\]. Commonly used bowel preparation enema and laxative methods include polyethylene glycol (PEG) and sodium picosulfate solution (Picoprep), respectively \[[@R12], [@R13]\].

The use of polyethylene glycol (PEG) has been associated with numerous adverse effects including nausea, vomiting, bloating and abdominal cramps \[[@R10]\]. On the other hand, sodium picosulfate solution, a combination of magnesium oxide and citric acid, manufactured by Ferring Pharmaceuticals, Parsippany, NJ, has been demonstrated to have fewer adverse effects. It is an effective, low volume bowel cleansing product with excellent effectiveness, adequate tolerance, and less electrolyte imbalance compared to PEG \[[@R10], [@R14]\].

Despite the acceptable effectiveness and safety of both bowel cleansing methods, very few studies have been performed to test which method is more effective. Specifically, to the best of our knowledge, no study has been conducted to evaluate and compare the quality of bowel preparations using different oral-cleansing solutions versus BCDs. We therefore performed an observational study followed by propensity score modeling to evaluate and compare the quality of bowel preparation with the use of Aquanet BCDs versus the use of oral sodium picosulfate solution.

Methods {#s2}
=======

Study design {#s2a}
------------

We performed a prospective cross-sectional study to compare the quality of pre-endoscopic bowel preparation using a BCD with oral sodium picosulfate solution. A total of 314 participants were part of our study, and the study was described in accordance with the STROBE (Strengthening the Reporting of Observational studies in Epidemiology) guidelines \[[@R15]\].

Ethics {#s2b}
------

This study was evaluated and approved by the Research Ethics Committee of the Portuguese Charitable Hospital (protocol number 655036, May 19, 2014) in Sao Jose do Rio Preto, SP, Brazil, and informed consent was offered to all potential participants and subsequently signed prior to any study protocol being implemented.

Setting {#s2c}
-------

Data collection was performed from June 2014 to February 2015 at the Portuguese Charitable Hospital, located at Sao Jose do Rio Preto, SP, Brazil. Patients came from Sao Paulo state. The Kaiser clinic, a private institution, paid for the Aquanet devices. The Aquanet devices were designed and tested by Prime Pacific Health Innovations Corporation (<http://www.primepacifichealth.com/aquanet-family-of-colon-hydrotherapy-devices/>, last accessed December 2016), and approved by the various regulatory authorities for market approval and licensing including FDA, Health Canada, and EU (<http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K000031>, last accessed December 2016). The procedure was inexpensive and the process lasted 40 - 60 min. It makes use of filtered, ultraviolet treated water and derives the water pressure from gravity or from a pump with an upper safe limit of 2 per square inch (psi) of pressure. The device cleanses the large bowel through a series of fill and empty cycles by hydrating the colon, stimulating peristalsis and evacuating bowel contents. The process is intended to hydrate the colon without a significant loss of electrolytes. Although no significant adverse events have been reported as of December of 2016, the device may cause mild abdominal discomfort during the water infusion phase in some patients.

Participants {#s2d}
------------

Our participants were selected among all patients requiring a colonoscopy. We included those between the ages of 14 and 90 years, and who also presented more than three bowel movements per week for the past 1 month. We excluded those who had the following conditions: pregnancy (confirmed by a pregnancy test), acute abdomen syndrome, prior colorectal surgery, hemorrhoids or endoscopic procedures, known bowel diseases (colon cancer history, toxic megacolon, toxic colitis, idiopathic pseudo obstruction, hypo-motility syndrome), other gastrointestinal disorders (active ulcer, output obstruction, retention, gastroparesis, ileus), previous upper gastrointestinal surgery (gastrectomy, gastric band, gastric bypass), uncontrolled angina and/or myocardial infarction (MI) within the last 3 months, congestive heart failure (CHF) or uncontrolled hypertension, renal impairment (serum, creatinine and potassium must be within normal limits) or known hypersensitivity to active ingredients.

Outcome variables {#s2e}
-----------------

Our major outcome of interest was the quality of bowel preparation as measured through the Boston bowel preparation (BBP) scale. Bowel preparation was evaluated in three segments: the right segment (cecum and ascending colons), transverse segment (transverse colon including liver and splenic angles), and the left segment (descending and sigmoid colons and rectum). Each segment was evaluated on a scale from 0 to 3, and the final score for an individual was the sum of scores for all three segments. Using this score, 0 was the minimum score corresponding to an unprepared colon and 9 was the maximum score corresponding to an excellent preparation without any residual traces \[[@R16]\]. Inadequate preparation corresponded to a BBP score of less than 5 \[[@R17], [@R18]\].

Predicting variables {#s2f}
--------------------

Our main predictor was the method of bowel preparation. The bowel was prepared using either sodium picosulfate or the BCD. On the day prior to the colonoscopy, all participants on sodium picosulfate took four tablets of Dulcolax with tea or water in the morning, liquid diet (juice, tea or water) at lunch, two capsules of 25 mg Dramamine Capsgel in the afternoon, sodium picosulfate dissolved in 150 mL of cold water 30 min after, followed by drinking at least five 250 mL cups of water or other light liquids till midnight, with absolute fasting until the colonoscopy was performed. For bowel preparation with the BCD, intestinal lavage was performed with the device, and made use of water, pressure, and gravity to enhance bowel cleansing. The water used in this procedure was previously triple-filtered by its passage on carbon, micro-pellets and ultraviolet light. The preparation was carried out by a trained nurse. All endoscopies were performed by an endoscopist who was blinded to the method of preparation.

Potential confounding variables {#s2g}
-------------------------------

Our potential confounders were selected based on evidence from previous literature combined with our clinical judgment. Specifically, we selected age and gender as potential confounders \[[@R19]\].

Statistical methods {#s2h}
-------------------

Our exploratory analysis was started by evaluating distributions, frequencies and percentages for each of the numeric and categorical variables. Categorical variables were evaluated for near-zero variation \[[@R20]\]. Extensive graphical displays were used for both univariate analysis and bivariate associations, accompanied by broader tests such as maximal information coefficient \[[@R21]\] and non-negative matrix factorization \[[@R22]\] algorithms for numeric variables. Missing data were explored using a combination of graphical displays involving univariate, bivariate and multivariate methods. Imputation was performed using a k-nearest neighbors algorithm (n = 5) \[[@R23]\].

The association between bowel cleansing procedures and quality of bowel cleansing was evaluated using propensity matching scores. The analysis was started by building propensity scores using the bowel cleansing procedure as a dependent variable and our previously listed potential confounders as predictors. Propensity scores (alpha = 20) were then matched between the two arms of our interventions, their balance evaluated through a combination of plots as well as statistical tests, specifically *t*-tests and Chi-square tests. Once matched controls were found, comparisons were conducted between Aquanet vs. sodium picosulfate procedures in predicting quality of bowel cleansing. Variables which did not balance after matching were further adjusted for in a generalized linear model \[[@R24]\].

All analyses were performed using the R language \[[@R22]\] and the following packages: ggplot2, rmarkdown, and non-random.

Results {#s3}
=======

Participants {#s3a}
------------

A total of 314 participants were part of this analysis. Average age was 54 years old, with most participants being females (81%). Some of the participants had constipation (14.6%) ([Table 1](#T1){ref-type="table"}).

###### Baseline Characteristics of Participants Stratified by Bowel Preparation

  Variable              Total (314)     Aquanet (157)   Sodium picosulfate (157)   P
  --------------------- --------------- --------------- -------------------------- ----------
  Age                   54.22 ± 17.61   58.2 ± 16.87    50.24 ± 17.48              \< 0.001
  Gender (female)       254 (80.9%)     143 (91.1%)     111 (70.7%)                \< 0.001
  Intestinal symptoms                                                              0.017
    Constipated         46 (14.6%)      15 (9.6%)       31 (19.7%)                 
    Normal              268 (85.4%)     142 (90.4%)     126 (80.3%)                

Outcomes {#s3b}
--------

When evaluating the quality of bowel cleansing by intervention and then at each segment, we observed that bowel cleansing was associated with better scores in the distal colon compared to the proximal colon for both methods. The distal colon was associated with the worse cleansing scores ([Table 2](#T2){ref-type="table"}). In addition, sodium picosulfate was more effective with better total scores (7.28 ± 1.95, 88.5%) when compared to a BCD (6.02 ± 2.51, 68.8%).

###### Boston Scores for Bowel Segments Stratified by Bowel Preparation

  Variable           Total (314)    Aquanet (157)   Sodium picosulfate (157)   P
  ------------------ -------------- --------------- -------------------------- ----------
  Rectum                                                                       0.002
    1                27 (8.6%)      22 (14%)        5 (3.2%)                   
    2                37 (11.8%)     19 (12.1%)      18 (11.5%)                 
    3                250 (79.6%)    116 (73.9%)     134 (85.4%)                
  Sigmoid colon                                                                \< 0.001
    0                7 (2.2%)       4 (2.5%)        3 (1.9%)                   
    1                44 (14%)       34 (21.7%)      10 (6.4%)                  
    2                42 (13.4%)     22 (14%)        20 (12.7%)                 
    3                221 (70.4%)    97 (61.8%)      124 (79%)                  
  Descending colon                                  r                          \< 0.001
    1                56 (17.8%)     44 (28%)        12 (7.6%)                  
    2                53 (16.9%)     23 (14.6%)      30 (19.1%)                 
    3                205 (65.3%)    90 (57.3%)      115 (73.2%)                
  Transverse colon                                                             \< 0.001
    0                1 (0.3%)       1 (0.6%)        0 (0%)                     
    1                64 (20.4%)     48 (30.6%)      16 (10.2%)                 
    2                52 (16.6%)     24 (15.3%)      28 (17.8%)                 
    3                197 (62.7%)    84 (53.5%)      113 (72%)                  
  Ascending colon                                                              \< 0.001
    0                11 (3.5%)      9 (5.7%)        2 (1.3%)                   
    1                78 (24.9%)     56 (35.7%)      22 (14.1%)                 
    2                62 (19.8%)     25 (15.9%)      37 (23.7%)                 
    3                162 (51.8%)    67 (42.7%)      95 (60.9%)                 
  Cecum                                                                        \< 0.001
    0                12 ( 3.8 % )   10 (6.4 %)      2 (1.3%)                   
    1                103 (32.8%)    74 (47.1%)      29 (18.5%)                 
    2                77 (24.5%)     27 (17.2%)      50 (31.8%)                 
    3                122 (38.9%)    46 (29.3%)      76 (48.4%)                 
  Ileum                                                                        \< 0.001
    0                34 (10.8%)     19 (12.1%)      15 (9.6%)                  
    1                40 (12.7%)     34 (21.7%)      6 (3.8%)                   
    2                37 (11.8%)     18 (11.5%)      19 (12.1%)                 
    3                203 (64.6%)    86 (54.8%)      117 (74.5%)                
  Left                                                                         \< 0.001
    0                7 (2.2%)       4 (2.5% )       3 (1.9%)                   
    1                54 (17.2%)     42 (26.8%)      12 (7.6%)                  
    2                54 (17.2%)     23 (14.6%)      31 (19.7%)                 
    3                199 (63.4%)    88 (56.1%)      111 (70.7%)                
  Right                                                                        \< 0.001
    0                44 (14%)       27 (17.2%)      17 (10.8%)                 
    1                83 (26.4%)     61 (38.9%)      22 (14%)                   
    2                74 (23.6%)     23 (14.6%)      51 (32.5%)                 
    3                113 (36%)      46 (29.3%)      67 (42.7%)                 
  Total              6.65 ± 2.33    6.02 ± 2.51     7.28 ± 1.95                \< 0.001
  Total category                                                               \< 0.001
    Bad (0 - 4)      67 (21.3%)     49 (31.2%)      18 (11.5%)                 
    Good (5 - 9)     247 (78.7%)    108 (68.8%)     139 (88.5%)                

Propensity score matching {#s3c}
-------------------------

After a 1:1 matching, groups were tested for balance for each covariate using standard differences with an alpha of 20. While gender was balanced after matching, age remained unbalanced ([Fig. 1](#F1){ref-type="fig"}).

![Testing for balance after matching.](gr-11-018-g001){#F1}

Outcomes evaluation after propensity score matching {#s3d}
---------------------------------------------------

When evaluating outcomes through propensity scores with a 1:1 match for the treatment (Aquanet) group, and then further adjusting for the unbalanced variable (age), we found that despite the apparent superior cleansing performance of sodium picosulfate over the BCD, the difference was not statistically significant ([Table 3](#T3){ref-type="table"}).

###### Predicted Boston Scores: Crude Scores, Scores After Propensity Matching and After Adjusting for Age

  Model        Sodium picosulfate   Aquanet (bowel cleansing device)
  ------------ -------------------- ----------------------------------
  Crude        7.28 (6.93, 7.63)    6.02 (5.52, 6.52)
  Unadjusted   7.16 (6.76, 7.55)    5.92 (5.39, 6.45)
  Adjusted     8.6 (7.66, 9.53)     7.54 (7, 8.08)

Discussion {#s4}
==========

To our knowledge, this is the first study to compare the quality of bowel preparation for colonoscopy using a BCD (ColonoScoPrep™ or Aquanet) versus sodium picosulfate oral solution. Our analyses demonstrated that the device was as effective as the oral preparation when evaluated through the BBP scale, with maximum adjusted scores being 7.5 and 8.6, respectively (all scores with P \> 0.05).

Our results are aligned to previous reports on the effectiveness of both techniques on bowel cleansing \[[@R06], [@R10], [@R25]\]. As the level of effectiveness was similar between both methods, tolerability and safety must be decisive factors when making a choice \[[@R26]\]. Poorly tolerated methods tend to not be performed according to their instructions especially when used at home by patients, resulting in inadequate bowel preparation \[[@R27]\].

Sodium picosulfate is a stimulant laxative associated with abdominal discomfort, risk of electrolyte alterations and dehydration \[[@R28]\]. In contrast, ColonoScoPrep™ is a water-based filtration system, providing not only an efficient and safe intestinal washing along with high satisfaction and comfort levels by patients, but has also been associated with minimal changes in electrolyte levels \[[@R05], [@R29]\]. Hence, ColonoScoPrep™ might be suitable for patients vulnerable to hydro-electrolytic imbalance. BCDs however, are not recommended for patients with inflammatory bowel disease, perianal disease or obstructive symptoms \[[@R05]\].

BCDs present a number of other advantages. First, the procedure can be performed right before the colonoscopy, which is convenient for patients, only requiring the use of laxatives on the preceding night \[[@R15]\]. Sodium picosulfate in contrast, demands three intakes of a laxative solution as well as a restrictive diet during the day prior to the colonoscopy \[[@R30]\]. Given the ease in performing the exam with BCDs, the adherence to the procedure may be improved. As a consequence, when considering both procedures from a healthcare policy perspective, ColonoScoPrep™ might lead to a potential decrease in morbi-mortality, with costs justifying the indication of this device as an attractive choice for colonoscopy preparation \[[@R05]\].

Despite filling an important gap in the literature, our study does have limitations. First, the propensity score does not balance unmeasured confounding variables as would be the case with a randomized controlled trial. Second, although we attempted to be as inclusive as possible in our criteria and recruitment strategies, interventional studies tend to over-select patients who, compared to the general population, do not have as many comorbidities, are more educated, are not as representative of minority groups, and have a greater income. Despite these limitations, we believe that the internal validity provided through our propensity score-matching establishes an important new ground of evidence in the field.

In conclusion, this study reinforces previous reports regarding the quality of BCDs, indicating that this technique should be considered for colonoscopy preparation. In the future, randomized controlled trials should be performed to validate these preliminary findings.

We received statistical and English reviewing assistance from SporeData Inc.

Author Contributions {#s4a1}
====================

Dr Kaiser Junior had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Conception and design: Roberto Luiz Kaiser Junior, Luiz Gustavo de Quadros, and Mikaell Alexandre Gouvea Faria. Analysis and interpretation: Luiz Gustavo de Quadros and Fernanda Soubhia Liedtke Kaiser. Drafting of the manuscript: Roberto Luiz Kaiser Junior, Luiz Gustavo de Quadros, Fernanda Soubhia Liedtke Kaiser, Juan Carlos Ochoa Campo, and Idiberto Jose Zotarelli Filho. Reviewing: Roberto Luiz Kaiser Junior, Luiz Gustavo de Quadros, and Mikaell anAlexandre Gouvea Faria. Final approval of the manuscript: Roberto Luiz Kaiser Junior.

Funding Support {#s4a2}
===============

None.
